PMC:7321036 / 5339-5641 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T127","span":{"begin":18,"end":22},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T128","span":{"begin":189,"end":199},"obj":"SP_7"}],"text":"to be established drug targets with therapeutic potential (Ochoa et al., 2016, 2020). Here we present a quantitative survey of the global phosphorylation and protein abundance landscape of SARS-CoV-2 infection, map phosphorylation changes to disrupted kinases and pathways, and use these profiles to ra"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T11364","span":{"begin":158,"end":165},"obj":"Body_part"},{"id":"T97555","span":{"begin":211,"end":214},"obj":"Body_part"}],"attributes":[{"id":"A47174","pred":"fma_id","subj":"T11364","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A99359","pred":"fma_id","subj":"T97555","obj":"http://purl.org/sig/ont/fma/fma67847"}],"text":"to be established drug targets with therapeutic potential (Ochoa et al., 2016, 2020). Here we present a quantitative survey of the global phosphorylation and protein abundance landscape of SARS-CoV-2 infection, map phosphorylation changes to disrupted kinases and pathways, and use these profiles to ra"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T47","span":{"begin":189,"end":197},"obj":"Disease"},{"id":"T48","span":{"begin":200,"end":209},"obj":"Disease"}],"attributes":[{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A48","pred":"mondo_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"to be established drug targets with therapeutic potential (Ochoa et al., 2016, 2020). Here we present a quantitative survey of the global phosphorylation and protein abundance landscape of SARS-CoV-2 infection, map phosphorylation changes to disrupted kinases and pathways, and use these profiles to ra"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T66438","span":{"begin":102,"end":103},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"to be established drug targets with therapeutic potential (Ochoa et al., 2016, 2020). Here we present a quantitative survey of the global phosphorylation and protein abundance landscape of SARS-CoV-2 infection, map phosphorylation changes to disrupted kinases and pathways, and use these profiles to ra"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T21","span":{"begin":18,"end":22},"obj":"Chemical"},{"id":"T22","span":{"begin":158,"end":165},"obj":"Chemical"}],"attributes":[{"id":"A21","pred":"chebi_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A22","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"to be established drug targets with therapeutic potential (Ochoa et al., 2016, 2020). Here we present a quantitative survey of the global phosphorylation and protein abundance landscape of SARS-CoV-2 infection, map phosphorylation changes to disrupted kinases and pathways, and use these profiles to ra"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3276","span":{"begin":138,"end":153},"obj":"http://purl.obolibrary.org/obo/GO_0016310"},{"id":"T79869","span":{"begin":215,"end":230},"obj":"http://purl.obolibrary.org/obo/GO_0016310"}],"text":"to be established drug targets with therapeutic potential (Ochoa et al., 2016, 2020). Here we present a quantitative survey of the global phosphorylation and protein abundance landscape of SARS-CoV-2 infection, map phosphorylation changes to disrupted kinases and pathways, and use these profiles to ra"}

{"project":"LitCovid-PubTator","denotations":[{"id":"132","span":{"begin":189,"end":209},"obj":"Disease"}],"attributes":[{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"to be established drug targets with therapeutic potential (Ochoa et al., 2016, 2020). Here we present a quantitative survey of the global phosphorylation and protein abundance landscape of SARS-CoV-2 infection, map phosphorylation changes to disrupted kinases and pathways, and use these profiles to ra"}

{"project":"2_test","denotations":[{"id":"32645325-27909043-20773040","span":{"begin":73,"end":77},"obj":"27909043"},{"id":"32645325-31819260-20773041","span":{"begin":79,"end":83},"obj":"31819260"}],"text":"to be established drug targets with therapeutic potential (Ochoa et al., 2016, 2020). Here we present a quantitative survey of the global phosphorylation and protein abundance landscape of SARS-CoV-2 infection, map phosphorylation changes to disrupted kinases and pathways, and use these profiles to ra"}